A team of Israeli scientists are claiming that they have found a cure for cancer, and it will be available in a year’s time.
The Jerusalem Post reports that the Accelerated Evolution Biotechnologies (AEBi) company is utilizing peptides, which are chains of amino acids, to target and kill cancer cells without affecting the healthy cells in a patient’s body.
The treatment, which AEBi is calling MuTaTo (multi-target toxin), would involve patients providing part of their biopsy for doctors to determine the specific cancer cells to target, and then form a molecule cocktail to destroy the tumor.
“Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market,” AEBi board chairman Dan Aridor told the Post. “Our solution will be both generic and personal.”
However, some doctors are skeptical about the approach, arguing that peptides are too short-lived to carry out a sustained attack on cancer cells and that the AEBi’s treatment has only been used on mice.
“As experience has taught us so many times, the gap from a successful mouse experiment to effective, beneficial application of exciting laboratory concepts to helping cancer patients at the bedside is in fact a long and treacherous journey, filled with unforeseen and unanticipated obstacles,” Dr. Len Lichtenfeld, chief medical officer of the American Cancer Society (ACS), told the UK Daily Mail.
This article has been modified to state that Dr. Lichtenfeld is the chief medical officer of the American Cancer Society.
